Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/06/1998 | US5817336 Composition containing selegiline |
10/06/1998 | US5817333 Fk-506 |
10/06/1998 | US5817332 Transdermal drug delivery system |
10/06/1998 | US5817331 Absorption; drug delivery device |
10/06/1998 | US5817330 Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation |
10/06/1998 | US5817322 Pharmaceutical base and the use of the same |
10/06/1998 | US5817321 Biological agent compositions |
10/06/1998 | US5817312 Sprayable immunoglobulins |
10/06/1998 | US5817293 Canister containing aerosol formulations containing P134a and particulate medicaments |
10/06/1998 | US5817028 Method and device for the provocation of air passage narrowing and/or the induction of sputum |
10/06/1998 | US5816260 Method for treating substance abuse withdrawal |
10/06/1998 | CA2168131C Tetrahydro-1h-benzazepinones containing acid surrogates |
10/06/1998 | CA2167715C Heteroaryl cycloalkenyl hydroxyureas |
10/06/1998 | CA2156515C Process for the preparation of a water-dispersible carotenoid preparation in powder form |
10/06/1998 | CA2136841C Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis |
10/06/1998 | CA2128099C Antimicrobial interferon-inducing medicament |
10/06/1998 | CA2012313C Thienylacetic acid derivatives, process for the preparation thereof, the use thereof, and pharmaceuticals containing these and the preparation thereof |
10/06/1998 | CA1340074C Benzodiazepines, process and intermediates for the preparation thereof and their applications in therapy |
10/05/1998 | CA2216215A1 Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
10/04/1998 | CA2234139A1 Benzamide derivative, anti-ulcer drug, and antibacterial drug |
10/04/1998 | CA2234134A1 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug |
10/04/1998 | CA2233934A1 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug |
10/04/1998 | CA2233925A1 Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
10/03/1998 | CA2234272A1 Amino acid derivatives and active oxygen-resisting agent |
10/03/1998 | CA2232147A1 Phenoxymethyl piperidine derivatives |
10/02/1998 | CA2233787A1 Sialoadhesin family member-3 |
10/02/1998 | CA2233682A1 Dithiolan derivatives, their preparation and their therapeutic effect |
10/01/1998 | WO1998043081A1 Treatment of gastrointestinal disease with ppar modulators |
10/01/1998 | WO1998042868A2 Screening method for proline-rich proteins |
10/01/1998 | WO1998042820A1 Use of the antibacterial active substance triclocarbane in liquid soaps |
10/01/1998 | WO1998042754A2 Glycosaminoglycans having high antithrombotic activity |
10/01/1998 | WO1998042750A1 ANTIGENIC FUSIONPROTEIN CARRYING GALα1,3GAL EPITOPES |
10/01/1998 | WO1998042738A1 87 human secreted proteins |
10/01/1998 | WO1998042734A1 Process of purification of cyclosporin |
10/01/1998 | WO1998042729A2 Steroid sulfamates, method for the production and use thereof |
10/01/1998 | WO1998042725A1 Methods and compositions for diagnosis and treatment of breast cancer |
10/01/1998 | WO1998042713A1 2,3-DIHYDROFURO[3,2-b]PYRIDIN, PREPARATION AND APPLICATION THEREOF IN THERAPY |
10/01/1998 | WO1998042708A2 Pharmaceutically active tricyclic amines |
10/01/1998 | WO1998042706A1 Method of making arylamino triazolopyridines |
10/01/1998 | WO1998042705A1 Salt of naphthyridine carboxylic acid derivative |
10/01/1998 | WO1998042704A1 Improved method for producing thiazolidinediones, and new thiazolidinediones |
10/01/1998 | WO1998042701A1 3-oxadiazolylquinoxaline derivatives |
10/01/1998 | WO1998042696A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
10/01/1998 | WO1998042686A1 Ldl receptor gene expression promoters |
10/01/1998 | WO1998042675A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
10/01/1998 | WO1998042674A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
10/01/1998 | WO1998042673A1 Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
10/01/1998 | WO1998042670A1 Novel pyridine derivatives and pharmaceutical compositions containing them |
10/01/1998 | WO1998042667A1 Hetero-tricyclic compouds exhibiting inhibitory activity against nos |
10/01/1998 | WO1998042662A1 Certain cyclic thio substituted acylaminoacid amide derivatives |
10/01/1998 | WO1998042661A1 Aromatic and heterocyclic nitrato derivatives |
10/01/1998 | WO1998042659A2 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals |
10/01/1998 | WO1998042650A2 Leukotriene antagonists useful for treating cystic fibrosis |
10/01/1998 | WO1998042384A1 Methods for delivering bioactive agents |
10/01/1998 | WO1998042382A1 Pharmaceutical compositions containing propanamine derivatives and cyclodextrin |
10/01/1998 | WO1998042379A2 Chemically and thermally stable norastemizole formulations |
10/01/1998 | WO1998042355A1 Phosphate-binding polymers combined with a calcium supplement for oral administration |
10/01/1998 | WO1998042354A1 Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
10/01/1998 | WO1998042353A1 Modulation of human mast cell activation |
10/01/1998 | WO1998042352A1 Method for treating b-cell tumors with ara-g nucleoside derivatives |
10/01/1998 | WO1998042351A1 Difluoronucleoside phosphonic acids and derivatives thereof |
10/01/1998 | WO1998042350A1 Cholesterol lowering pharmaceutical composition |
10/01/1998 | WO1998042349A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread |
10/01/1998 | WO1998042348A1 Topical moisturizing composition and method |
10/01/1998 | WO1998042347A1 Pharmaceutical composition containing a phosphorylamide and an ayntibiotic |
10/01/1998 | WO1998042346A1 Leukotriene antagonists useful for treating ischemia reperfusion injury |
10/01/1998 | WO1998042345A1 Leukotriene antagonists useful for treating cerebral focal stroke |
10/01/1998 | WO1998042344A1 Pharmaceutical composition |
10/01/1998 | WO1998042343A1 Method for treatment of chronic bronchitis |
10/01/1998 | WO1998042342A1 Thrombin inhibitors |
10/01/1998 | WO1998042340A1 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus |
10/01/1998 | WO1998042339A1 Use of chelerythrine and radiation for tumor therapy |
10/01/1998 | WO1998042338A1 Extension of the expression of transgenic proteins by immunomodulation |
10/01/1998 | WO1998042337A1 Leukotriene antagonists useful for treating dermatoses |
10/01/1998 | WO1998042336A1 Leukotriene antagonists useful for treating gingivitis |
10/01/1998 | WO1998042335A1 Leukotriene antagonists useful for treating gout |
10/01/1998 | WO1998042334A1 Leukotriene antagonists useful for treating squamous cell carcinoma |
10/01/1998 | WO1998042333A1 Nasal melatonin composition |
10/01/1998 | WO1998042332A1 Leukotriene antagonists useful for treating iritis |
10/01/1998 | WO1998042331A1 Mediation of circadian rhythms |
10/01/1998 | WO1998042330A1 Methods and compositions for treatment of ovarian cancer |
10/01/1998 | WO1998042329A1 Preventives and/or remedies for diseases caused by abnormal neovascularization |
10/01/1998 | WO1998042328A1 Di-aryl ethers and their derivatives as anti-cancer agents |
10/01/1998 | WO1998042327A2 Vascular remodeling agent |
10/01/1998 | WO1998042326A1 Fungal sulphur source and method of using the same |
10/01/1998 | WO1998042325A2 INHIBITION OF THE CLEAVAGE OF PRECURSOR IL-1$g(b) |
10/01/1998 | WO1998042324A2 Methods for modulating neurotrophic factor-associated activity using aldose reductase inhibitors |
10/01/1998 | WO1998042323A1 Stabilized urease inhibitor |
10/01/1998 | WO1998042322A2 Antitussive compositions |
10/01/1998 | WO1998042321A2 Liquid compositions comprising lamivudine |
10/01/1998 | WO1998042318A1 Pellets having a core coated with an antifungal and a polymer |
10/01/1998 | WO1998042312A2 Medicament having sclerosing activity |
10/01/1998 | WO1998042311A1 Gastrointestinal mucosa-adherent pharmaceutical composition |
10/01/1998 | WO1998042310A2 Fast release compressed tablet of flurbiprofen |
10/01/1998 | WO1998042309A1 Topical moisturizing composition and method |
10/01/1998 | WO1998042275A1 Method of treatment of migraine |
10/01/1998 | WO1998042270A1 Bone marrow as a site for transplantation |
10/01/1998 | WO1998042191A1 Process and means for the eradication of ticks in the habitats of small mammals |
10/01/1998 | WO1998042188A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
10/01/1998 | WO1998029104A3 Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis |